Cogent Biosciences
COGT
30.14
-0.24
-0.79%
Cogent Biosciences
US · COGT
#2052 by market cap
Listed 2016
30.14
-0.24
-0.79%
Live - 5344 symbols - heartbeat 415s ago
· 2026-10-08 04:11
Pre-market
30.24
+0.33%
After-hours
30.14
0.00%
- Market cap
- 5.23B
- P/E (TTM)i
- -13.95
- P/Bi
- 11.18
- EPSi
- -2.16
- Div yieldi
- 0.00%
- 52W posi
- 55%
Reader sentiment
Are you bullish or bearish on COGT?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 7 analysts
Buy
Avg price target
55.67 +84.7%
Price target rangecurrent 30.14
Low52.00
Avg55.67
High62.00
Buy 86%
Hold 14%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-16 | Wedbush | -- | BUY | 55.00 |
| 2026-09-16 | H.C. Wainwright | -- | BUY | 55.00 |
| 2026-09-15 | LifeSci Capital | -- | BUY | 55.00 |
| 2026-09-15 | H.C. Wainwright | -- | BUY | 55.00 |
| 2026-09-09 | J.P. Morgan | -- | BUY | 62.00 |
| 2026-08-21 | H.C. Wainwright | -- | BUY | 55.00 |
| 2026-08-19 | H.C. Wainwright | -- | BUY | 55.00 |
| 2026-08-17 | Piper Sandler | -- | BUY | 55.00 |
| 2026-08-11 | Wedbush | -- | BUY | 55.00 |
| 2026-08-11 | Needham | -- | HOLD | -- |
| 2026-08-11 | Guggenheim | -- | BUY | 52.00 |
| 2026-08-10 | LifeSci Capital | -- | BUY | 55.00 |
| 2026-08-10 | Needham | -- | HOLD | -- |
| 2026-06-18 | H.C. Wainwright | -- | BUY | 55.00 |
| 2026-06-17 | H.C. Wainwright | -- | BUY | 55.00 |
| 2026-06-15 | Wedbush | -- | BUY | 55.00 |
| 2026-06-15 | Stifel | -- | BUY | 45.00 |
| 2026-06-01 | Stifel | -- | BUY | 45.00 |
| 2026-06-01 | H.C. Wainwright | -- | BUY | 55.00 |
| 2026-05-31 | UBS | -- | BUY | 60.00 |
| 2026-05-31 | J.P. Morgan | -- | BUY | -- |
| 2026-05-29 | Wedbush | -- | BUY | 55.00 |
| 2026-05-09 | LifeSci Capital | -- | BUY | 55.00 |
| 2026-05-07 | Piper Sandler | -- | BUY | 52.00 |
| 2026-05-06 | LifeSci Capital | -- | BUY | 55.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: Stifel moved from Hold to Buy on 2025-11-10.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2025-11-10 | Stifel | HOLD → BUY | 40.00 |
Quote time 2026-10-08 04:11:05 · For reference only, not investment advice and not tailored to your situation.